No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study

Papillomavirus Research
Sadao Suzuki, Akihiro Hosono

Abstract

Nagoya City introduced free HPV vaccination in 2010 and in April 2013 the Ministry of Health, Labour and Welfare included the HPV vaccine in the National Immunization Program. However, in June 2013, the Ministry suspended proactive recommendation of the vaccine after unconfirmed reports of adverse events. To investigate any potential association between the vaccine and reported symptoms, Nagoya City conducted a questionnaire-based survey. Participants were 71,177 female residents of Nagoya City born between April 2, 1994 and April 1, 2001. The anonymous postal questionnaire investigated the onset of 24 symptoms (primary outcome), associated hospital visits, frequency, and influence on school attendance. Totally, 29,846 residents responded. No significant increase in occurrence of any of the 24 reported post-HPV vaccination symptoms was found. The vaccine was associated with increased age-adjusted odds of hospital visits for "abnormal amount of menstrual bleeding" (OR: 1.43, 95% CI: 1.13-1.82), "irregular menstruation" (OR: 1.29, 95% CI: 1.12-1.49), "severe headaches" (OR: 1.19, 95% CI: 1.02-1.39), and chronic, persisting "abnormal amount of menstrual bleeding" (OR 1.41, 95% CI: 1.11-1.79). No symptoms significantly influenced s...Continue Reading

Citations

Aug 29, 2018·Journal of Clinical Medicine·Kazuhiro KobayashiTatsuhiko Miyazaki
Feb 16, 2019·Expert Review of Vaccines·Sayaka IkedaKazuya Kudoh
Jun 4, 2019·Japanese Journal of Infectious Diseases·Shinya MurataYoshiyuki Tanaka
Aug 29, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Raúl Murillo, Camila Ordóñez-Reyes
Jun 26, 2020·The Journal of Obstetrics and Gynaecology Research·Tatsuo MasudaTadashi Kimura
May 21, 2020·Human Vaccines & Immunotherapeutics·Li Ping WongGregory D Zimet
Jul 10, 2020·Vaccines·Masayuki SekineTakayuki Enomoto
Nov 28, 2018·Immunologic Research·Svetlana BlitshteynManuel Martinez-Lavin
Sep 14, 2019·Journal of General and Family Medicine·Kentaro Iwata, Yoshiaki Katsuda
Jan 8, 2021·PloS One·Shunji SuzukiTadaichi Kitamura
Nov 1, 2020·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Kuniyoshi MizumachiMidori Shima
Dec 4, 2020·The Lancet Oncology·Yusuke Tanaka
Oct 31, 2020·Human Vaccines & Immunotherapeutics·Akiko Tozawa-OnoKatsuyuki Kinoshita
Dec 29, 2020·Travel Medicine and Infectious Disease·Riko Muranaka
May 4, 2021·The Journal of Clinical Investigation·Tomohiro EnokidaNina Bhardwaj
Jun 5, 2021·Journal of Gynecologic Oncology·Sharon J B Hanley
Sep 17, 2021·BMJ : British Medical Journal·Victoria Male
Nov 23, 2021·Human Vaccines & Immunotherapeutics·Kosuke HiramatsuKentaro Shimura
Dec 6, 2021·International Journal of Epidemiology·Gemma C SharpJacqueline A Maybin
Dec 24, 2021·Expert Review of Vaccines·Erika Bohn-GoldbaumKate M Edwards

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Gan to kagaku ryoho. Cancer & chemotherapy
Hiroyuki Yoshikawa
Josanpu zasshi = The Japanese journal for midwife
S SakaguchiT Abe
Rinsho byori. The Japanese journal of clinical pathology
Nobuko KannoYutaka Yatomi
© 2022 Meta ULC. All rights reserved